Stephan Köhler
Germany
Review Article
Safety and Tolerability of EPs 7630 in Clinical Trials
Author(s): Heinrich Matthys, Stephan Köhler and Wolfgang KaminHeinrich Matthys, Stephan Köhler and Wolfgang Kamin
Herbal medicines play an increasingly important role in the perception of physicians and patients looking for equally effective, albeit safer approaches to conventional management of certain diseases. The controversy surrounding effective management regimes for respiratory tract infections (RTI) has made many healthcare providers reconsider current therapeutic strategies.
This review presenting the available evidence from clinical trials and non-interventional studies on the safety and tolerability profile of EPs 7630 is based on publications and study reports of 29 clinical trials and post-marketing surveillance studies completed by February 2010. It includes study data from 10,026 adults and children suffering from acute or chronic RTI such as acute tonsillopharyngitis, rhinopharyngitis, sinusitis, bronchitis, or COPD and from 31 healthy subjects.
In 19 double-blind,.. View More»
DOI:
10.4172/2167-1052.1000142